Blog / Archives
Rayno Life Science Portfolio Updates-AMRN GNMK TDOC ; XBI is up 30% YTD…Update-12/17
Update-12/17. Amarin (AMRN)- A Sell on the News? AMRN stock tanked another 6.7% today on last weekend's news of the FDA approval of VASCEPA. This is what happens with momentum stocks with a well...
Two Early Stage Biopharma Deals Focus on Oncology Assets…ARQL THOR…Update-1
Update-1 ...12/12/19...China Deal Announcement Boosts Dow S&P and NASDAQ. IBB up 0.68%, XBI up 0.58%, XLV up 0.93%. Large cap leaders: ABBV ALXN BMY, Chips, energy, financials strong; real...
Biotech Scoreboard-November: Gene Therapy Stocks Gain Momentum…Update-2– BOLD
Update-2 ...12/3...Biotech among the leading sectors on a sell-off day With NASDAQ off 0.55% and the S&P down 0.68%, biotech stocks were oblivious to the trade worries and had a huge rally...
Rayno BioBeat #3: Sentiment Shift Boosts Biotech and Healthcare Stocks Despite Political Undertow…Update-1 “green screen”
Update-1 11/25/19... Rally right on track driven by NVS/MDCO deal, new product surge and cheap money from FED. As we said many time on this site XBI is the bellwether up 4.25% today (UP 13% in one...
Healthcare Stocks Breakout and Biotech Stocks Rally Off the Bottom…Update-3 ALNY AMRN
Update-3 10/20...China Phase 1 deal stalled -curbs strong momentum in biopharma. Amarin (AMRN) getting beat up by an Oppenheimer skeptic who thinks Vascepa growth will be tepid. Despite tape...
Nice Gains for Biotech Today Big and Small…Update-2
Update-2...One of the best days of the year for us; I will summarize later. Only laggard sector was speculative microcaps. Some of our best gains among healthcare/life science stocks: ABBV AMRN CRSP...
Biotech and Healthcare Stocks Notch-Up with Bullish Tape Action
Biotech and Healthcare Stocks Notch -Up with Bullish Tape Action Since we called the early October reversal for healthcare and biotech stocks we have seen great gains of 5-7% with more gains ahead...
Biotech Action Today is Muddled
Biotech Action Today is Muddled-Midday Selloff presumably on "Recycling" of China Trade Chatter Uncertainty Remains on Trade War and Tariffs Little rally in gene therapy stocks; 1% + Winners include...
Biotech had a Great October Boosted by Large Cap Biopharma Leader…Update-1 AMRN, REGN
Update-1 11/5 2p EST IBB flat, NAZ up 0.185, earnings from AMRN and REGN. Amarin down 3.5% to $16.83 on earnings but bulls are waiting for label expansion. Q3 Revenues are $112.4 M up 103%,...
Small Cap Picks Update: AMRN, GNMK, TDOC…Update-2
Update-2 Genmark (GNMK) down 3.6 % to $5.61 on Q3 results. Beat on revenue to $20.9 M up 32 % over prior quarter, loss of 20 cents/share.Waiting for a buy-out in 2020? Update-1 ...Nov....